Radiopharmaceutical pharmacokinetics in animals: Critical considerations

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 4, 2009, Pages 359-364

  Giron, M C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Animals; Pharmacokinetics; Radiopharmaceuticals

Indexed keywords

2 IODOPHENYLALANINE I 123; ABC TRANSPORTER; FLUORODEOXYGLUCOSE F 18; ISOFLURANE; KETAMINE; N FLUOROETHYLPIPERIDINYLBENZILATE F 18; NITROUS OXIDE; PENTOBARBITAL; PROPOFOL; RADIOISOTOPE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; XYLAZINE;

ANESTHESIA; BLOOD BRAIN BARRIER; CONFERENCE PAPER; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BINDING; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; IN VIVO STUDY; ISOTOPE LABELING; NEUROIMAGING; NONHUMAN; PLASMA PROTEIN BINDING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

ANIMALS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 74949124493     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Giron MC, Portolan S, Bin A, Mazzi U, Cutler CS. Cytochrome P450 and radiopharmaceutical metabolism. Q J Nucl Med Mol Imaging 2008;52:254-66.
2. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152-62.
3. Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 2008;60:196-209.
4. Hermann DM, Bassetti CL. Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol Sci 2007;28:128-34.
5. Patel S, Gibson R. In vivo site-directed radiotracers: a mini-review. Nucl Med Biol 2008;35:805-15.
6. Syvänen S, Lindhe O, Palner M, Kornum BR, Rahman O, Lángström B et al. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 2009;37:635-43.
7. Liu X, Chen C, Smith BJ. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 2008;325:349-56.
8. Collins JM, Klecker RW Jr. Evaluation of highly bound drugs: interspecies, intersubject, and related comparisons. J Clin Pharmacol 2002;42:971-5.
9. Singh SS. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 2006;7:165-82.
10. Ascoli GA, Domenici E, Bertucci C. Drug binding to human serum albumin: a bridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 2006;18:667-79.
11. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981;33:17-53.
12. Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins: I. Drug binding sites. Pharm Res 1997;14:1607-12.
13. Kawai K, Nishii R, Shikano N, Makino N, Kuga N, Yoshimoto M et al. Serum protein binding displacement: theoretical analysis using a hypothetical radiopharmaceutical and experimental analysis with 123I-N-isopropyl-p- iodoamphetamine. Nucl Med Biol 2009;36:99-106.
14. Basken NE, Mathias CJ, Lipka AE, Green MA. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol 2008;35:281-6.
15. Colby LA, Morenko BJ. Clinical considerations in rodent bioimaging. Comp Med 2004;54:623-30.
16. Kilbourn MR, Ma B, Butch ER, Quesada C, Sherman PS. Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor. Nucl Med Biol 2007;34:479-82.
17. Meyer PT, Salber D, Schiefer J, Cremer M, Schaefer WM, Kosinski CM et al. Cerebral kinetics of the dopamine D(2) receptor ligand [123I]IBZM in mice. Nucl Med Biol 2008;35:467-73.
18. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N et al. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 1999;849:85-96.
19. Elena G, Amerio N, Ferrero P, Bay ML, Valenti J, Colucci D et al. Effects of repetitive sevoflurane anaesthesia on immune response, select biochemical parameters and organ histology in mice. Lab Anim 2003;37:193-203.
20. Kersemans V, De Spiegeleer B, Mertens J, Siegers G. Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice. Nucl Med Biol 2006;33:119-23.
21. Woo SK, Lee TS, Kim KM, Kim JY, Jung JH, Rang JH et al. Anesthesia condition for [18F]-FDG imaging of lung metastasis tumors using small animal PET. Nucl Med Biol 2008;35:143-50.
22. Hildebrandt IJ, Su H, Weber WA. Anesthesia and other considerations for in vivo imaging of small animals. ILAR J 2008;49:17-26.